TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Binab Bio-Innovation AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
672
|
790
|
858 |
| Financial expenses |
16
|
1
|
3 |
| Earnings before taxes |
6
|
-15
|
19 |
| EBITDA |
37
|
11
|
60 |
| Total assets |
320
|
361
|
485 |
| Current assets |
218
|
244
|
343 |
| Current liabilities |
92
|
139
|
246 |
| Equity capital |
227
|
221
|
236 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
70.9%
|
61.2%
|
48.7% |
| Turnover per employee |
672
|
790
|
858 |
| Profit as a percentage of turnover |
0.9%
|
-1.9%
|
2.2% |
| Return on assets (ROA) |
6.9%
|
-3.9%
|
4.5% |
| Current ratio |
237.0%
|
175.5%
|
139.4% |
| Return on equity (ROE) |
2.6%
|
-6.8%
|
8.1% |
| Change turnover |
-118
|
-68
|
126 |
| Change turnover % |
-15%
|
-8%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.